VKTX
R500#10 today
$26.97
+5.87% today ยท -2.76% 1W
Oct 15 close or latest
ReadoutWhy it's moving
Weight-loss drug makers rise on oral development news
- VKTX +5.87% on the last session vs SPY +0.13%: +5.7 pts of stock-specific move.
- Weight-loss drugs: Eli Lilly and Novo Nordisk are developing oral weight-loss drugs, per BusinessWorld Online. (BusinessWorld Online)
- Weight-loss drugs basket +3.9% (+3.8 pts vs SPY; LLY +4.3%, NVO +3.6%): the stock moved with its peers.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Assembled from Wallsti's own signals and the session's headlines and filings read by AI (Claude); it can misread, so the sources are linked.
Aftermath covers the S&P 500 and the stocks discussed on Reddit; VKTX is not among them yet.